Gilead Sciences (GILD) Current Deferred Tax Assets (2009 - 2016)

Gilead Sciences (GILD) has 8 years of Current Deferred Tax Assets data on file, last reported at $857.0 million in Q4 2016.

• Quarterly Current Deferred Tax Assets rose 3.5% year-over-year to $857.0 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $857.0 million (up 3.5% YoY) and the FY2016 annual result came in at $857.0 million, up 3.5% from the prior year.
• Current Deferred Tax Assets rose to $857.0 million in Q4 2016, from $762.0 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $894.0 million in Q3 2015 to a low of $193.9 million in Q1 2012.
• A 5-year average of $501.1 million and a median of $385.6 million in 2014 frame the typical range for Current Deferred Tax Assets.
• Annual changes were most pronounced in 2012 — Current Deferred Tax Assets slumped 30.2% — and 2015, when it jumped 132.46%.
• Tracing GILD's Current Deferred Tax Assets over 5 years: stood at $262.6 million in 2012, then gained by 26.03% to $331.0 million in 2013, then jumped by 53.47% to $508.0 million in 2014, then soared by 62.99% to $828.0 million in 2015, then grew by 3.5% to $857.0 million in 2016.
• The last three Current Deferred Tax Assets figures came in at $857.0 million (Q4 2016), $762.0 million (Q3 2016), and $835.0 million (Q2 2016), per Business Quant data.